Multiparametric magnetic resonance imaging: Current role in prostate cancer management
Authors:
Open Access
- 17 May 2016
- journal article
- review article
- Published by Wiley in International Journal of Urology
- Vol. 23 (7) , 550-557
Abstract
Digital rectal examination, serum prostate‐specific antigen screening and transrectal ultrasound‐guided biopsy are conventionally used as screening, diagnostic and surveillance tools for prostate cancer. However, they have limited sensitivity and specificity. In recent years, the role of multiparametric magnetic resonance imaging has steadily grown, and is now part of the standard clinical management in many institutions. In multiparametric magnetic resonance imaging, the morphological assessment of T2‐weighted imaging is correlated with diffusion‐weighted imaging, dynamic contrast‐enhanced imaging perfusion and/or magnetic resonance spectroscopic imaging. Multiparametric magnetic resonance imaging is currently regarded as the most sensitive and specific imaging technique for the evaluation of prostate cancer, including detection, staging, localization and aggressiveness evaluation. This article presents an overview of multiparametric magnetic resonance imaging, and discusses the current role of multiparametric magnetic resonance imaging in the different fields of prostate cancer management.Keywords
This publication has 73 references indexed in Scilit:
- Prostate MRI: Who, when, and how? Report from a UK consensus meetingClinical Radiology, 2013
- Role of Magnetic Resonance Imaging in the Detection of Local Prostate Cancer Recurrence after External Beam Radiotherapy and Radical ProstatectomyClinical Oncology, 2013
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS StudyEuropean Urology, 2013
- Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound BiopsiesJournal of Urology, 2012
- Overview of Dynamic Contrast-Enhanced MRI in Prostate Cancer Diagnosis and ManagementAmerican Journal of Roentgenology, 2012
- Value of the Hemorrhage Exclusion Sign on T1-weighted Prostate MR Images for the Detection of Prostate CancerRadiology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillanceBritish Journal of Radiology, 2011
- Prospective Study of Prostate Tumor Angiogenesis and Cancer-Specific Mortality in the Health Professionals Follow-Up StudyJournal of Clinical Oncology, 2009
- Quel bilan d’imagerie avant une radiothérapie de rattrapage après prostatectomie radicale pour adénocarcinome prostatique ?Cancer/Radiothérapie, 2009